Protalex
Florham Park, US · Delaware corporation
Founders & leadership
KM
Kirk M WarshawExecutive
Board
AP
Arnold P KlingBoard director
ME
Marco ElserBoard director
Reported raises · per SEC filings
Form D private placements$4.3M disclosed across 2 rounds · 2014–2018
▶$1.4MraisedMar 2018 · 8 investors · BiotechnologyRule 506(b)
▶$1.4MraisedMar 2018 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Arnold P KlingExecutive Officer, Director
- Marco ElserDirector
- Kirk M WarshawExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.4M
- Minimum investment
- $50K
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b, 4a5
▶$2.8MraisedJan 2014 · 23 investors · OtherRule 506(b)
▶$2.8MraisedJan 2014 · 23 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- ARNOLD P KLINGExecutive Officer, Director
- KIRK M WARSHAWExecutive Officer, Director
- Offering amount
- $2.8M
- Amount sold
- $2.8M
- Minimum investment
- $10K
- First sale
- Jan 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b, 4a5
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Protalex raised?
- Protalex has disclosed $4.3M raised across 2 rounds.
- Where is Protalex headquartered?
- Protalex is headquartered in Florham Park, US.